• Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Buy" by Analysts

    Source: Buzz FX / 03 Nov 2024 02:01:16   America/New_York


    Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat November 3, 2024 Share Link copied to clipboard. Pliant Therapeutics, Inc. ( NASDAQ:PLRX - Get Free Report ) has earned an ave
    Read more...
Share on,